Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy. (Q37715274)
Jump to navigation
Jump to search
scientific article published on 19 March 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy. |
scientific article published on 19 March 2010 |
Statements
Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy (English)
Liz Y Han
Tom van Hagen
Shibani Nicum
Karen Thomas
Michelle Harrison
Panagiotis Papadopoulos
Peter Blake
Desmond P J Barton
Martin Gore